FI118513B - Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine - Google Patents

Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine Download PDF

Info

Publication number
FI118513B
FI118513B FI970703A FI970703A FI118513B FI 118513 B FI118513 B FI 118513B FI 970703 A FI970703 A FI 970703A FI 970703 A FI970703 A FI 970703A FI 118513 B FI118513 B FI 118513B
Authority
FI
Finland
Prior art keywords
collagen
treatment
calcitonin
osteoporosis
mmol
Prior art date
Application number
FI970703A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970703A (fi
FI970703A0 (fi
Inventor
Klaus Braeumer
Adam Milan
Bernd Eggersgluess
Reinhard Schrieber
Original Assignee
Dgf Stoess Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dgf Stoess Ag filed Critical Dgf Stoess Ag
Publication of FI970703A publication Critical patent/FI970703A/fi
Publication of FI970703A0 publication Critical patent/FI970703A0/fi
Application granted granted Critical
Publication of FI118513B publication Critical patent/FI118513B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
FI970703A 1994-08-23 1997-02-19 Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine FI118513B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4429842 1994-08-23
DE4429842 1994-08-23
EP9503304 1995-08-19
PCT/EP1995/003304 WO1996005851A1 (de) 1994-08-23 1995-08-19 Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe

Publications (3)

Publication Number Publication Date
FI970703A FI970703A (fi) 1997-02-19
FI970703A0 FI970703A0 (fi) 1997-02-19
FI118513B true FI118513B (fi) 2007-12-14

Family

ID=6526329

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970703A FI118513B (fi) 1994-08-23 1997-02-19 Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine

Country Status (12)

Country Link
US (1) US5948766A (no)
EP (1) EP0777491B1 (no)
JP (1) JPH10504555A (no)
AT (1) ATE282423T1 (no)
AU (1) AU703137B2 (no)
CA (1) CA2198099C (no)
DE (1) DE59510968D1 (no)
ES (1) ES2233947T3 (no)
FI (1) FI118513B (no)
NO (1) NO318182B1 (no)
PT (1) PT777491E (no)
WO (1) WO1996005851A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4609807B2 (ja) * 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) * 1997-06-18 1999-01-19 Zenyaku Kogyo Kk 骨粗鬆症予防・治療剤
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
JP2009148275A (ja) * 2000-08-30 2009-07-09 Morisuke Yokoyama 特定保健用食品
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP4766818B2 (ja) * 2002-07-24 2011-09-07 隆文 小濱 妊娠時に特異的な腰痛、股関節痛及び鼠径部痛の改善・治療剤
DE10339180A1 (de) * 2003-08-21 2005-03-24 Deutsche Gelatine-Fabriken Stoess Ag Kollagenhydrolysat
CA2603518C (en) * 2005-04-13 2013-11-26 Snow Brand Milk Products Co., Ltd. Nutrient composition for promoting collagen production
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8153162B2 (en) 2005-09-27 2012-04-10 Tissuetech, Inc. Purified amniotic membrane compositions and methods of use
ES2288791B1 (es) * 2006-02-10 2008-12-01 Masterfarm, S.L. Procedimiento de obtencion de un hidrolizado de colageno. hidrolizado enzimatico de colageno obtenible por el procedimiento y usos del mismo.
ES2298071B1 (es) * 2006-10-25 2009-07-28 Masterfarm,S.L. Hidrolizado enzimatico de colageno y procedimiento de obtencion.
EP2120989A1 (en) * 2007-03-21 2009-11-25 DSM IP Assets B.V. Cholesterol lowering protein hydrolysates
JP2008231065A (ja) * 2007-03-23 2008-10-02 Chisso Corp 骨代謝改善剤
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
DE102011000997A1 (de) * 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
DE102012110612A1 (de) 2012-11-06 2014-05-08 Gelita Ag Kollagenhydrolysat und dessen Verwendung
CA2937613C (en) 2013-01-23 2021-03-02 Bottled Science Limited Skin enhancing beverage composition
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
WO2018166807A1 (en) * 2017-03-15 2018-09-20 Rousselot B.V. Compositions of hydrolyzed collagen peptides and commensal microorganisms and methods thereof
DE102019202606A1 (de) 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102021119031B4 (de) 2021-07-22 2024-08-08 Manfred Lotz Behandlung von Polymyalgia Rheumatica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1227534A (no) * 1967-08-31 1971-04-07
CA1302880C (en) * 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CN1045719C (zh) * 1993-04-10 1999-10-20 北京市西城区华新生化技术研究所 口服接骨和治骨质疏松液
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases

Also Published As

Publication number Publication date
ES2233947T3 (es) 2005-06-16
EP0777491B1 (de) 2004-11-17
NO318182B1 (no) 2005-02-14
FI970703A (fi) 1997-02-19
CA2198099A1 (en) 1996-02-29
US5948766A (en) 1999-09-07
PT777491E (pt) 2005-01-31
JPH10504555A (ja) 1998-05-06
NO970805D0 (no) 1997-02-21
DE59510968D1 (de) 2004-12-23
FI970703A0 (fi) 1997-02-19
CA2198099C (en) 2001-01-16
WO1996005851A1 (de) 1996-02-29
ATE282423T1 (de) 2004-12-15
AU3347095A (en) 1996-03-14
NO970805L (no) 1997-02-21
EP0777491A1 (de) 1997-06-11
AU703137B2 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
FI118513B (fi) Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine
US4772591A (en) Method for accelerated wound healing
Levine et al. Intralesional verapamil injection for the treatment of Peyronie’s disease
JPH0696539B2 (ja) 関節の治療薬
JP3053116B2 (ja) 医薬組成物
US20070004629A1 (en) K9 and equine joint health food supplement and method of administering
Reisin et al. Effects of weight reduction on arterial pressure
JPH0769920A (ja) 骨量を増加するための副甲状腺ホルモンおよびラロキシフェン
DK177177B1 (da) Lindring af Peyronie's sygdom
JP2002523375A (ja) 骨の靭性、及び、剛性を増し、骨折を減少させる方法
JPH0651626B2 (ja) 組織退行性炎症性疾患の治療用組成物
US20030064975A1 (en) Hormone composition
Bauman et al. Effect of a vitamin D analog on leg bone mineral density in patients with chronic spinal cord injury.
ZA200402795B (en) Pharmaceutical compositions and methods for administering EP2 receptor selective agonists.
LARSEN Static or Dynamic Repair of Chronic Lateral Ankle Instability: A Prospective Randomized Study.
Mirovsky et al. Residual shortening after osteotomy for Perthes' disease. A comparative study
Grundnes et al. Mechanical effects of function on bone healing: nonweight bearing and exercise in osteotomized rats
EP1372731A2 (en) Polydimethylsiloxane preparation for nail, cartilage, bone and joint disorders
JP4652689B2 (ja) 骨再生を促進するカルモジュリンの使用
Pellicano et al. Multiple keratoacanthomas and junctional epidermolysis bullosa: a therapeutic conundrum
Kung The effect of thyroid hormone on bone metabolism and osteoporosis
JP2018535187A (ja) 選択的関節形成術を受けた患者の疼痛の治療のための組成物
JPH1192379A (ja) 骨疾患の予防または治療剤
RODRIGUEZ-MERCHANI et al. CEREBRAL, EMBOLISM DURING REVISION ARTHROPLASTY GGG GGL GLL
Khalid et al. Does the Crack Silently Break the Back?: Long-Term Follow-Up and Assessment of Risk Factors for Regional Osteoporosis Following Tibial Shaft Fractures

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118513

Country of ref document: FI